Translating Neurogenomics Into New Medicines

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Brain disorders represent a significant unmet medical need, with limited therapeutic options.
• Advances in human neurogenetics are illuminating the genetic basis of complex neurological and psychiatric conditions.
• Current understanding of genetic contributions to brain disorders is rapidly expanding.

Purpose of the Study:

• To review the current state of human neurogenetics.
• To identify critical challenges hindering the translation of genetic findings into therapeutics for brain disorders.
• To propose a path forward for efficient therapeutic development.

Main Methods:

• Review of recent advances in human neurogenetics, including genome-wide association studies (GWAS) and rare variant analysis.
• Analysis of the translational gap between genetic discoveries and clinical application.
• Identification and discussion of key challenges in neurogenetics research.

Main Results:

• Human neurogenetics provides insights into the pathogenesis of mood, cognitive, developmental, and neurodegenerative brain disorders.
• Translating genetic findings into novel therapeutics is a lengthy and complex process.
• Three major challenges impede efficient therapeutic translation from neurogenetics.

Conclusions:

• Addressing the identified challenges is crucial for accelerating the development of new medicines for brain disorders.
• Efficiently translating human genetics into therapeutics requires a concerted effort from the scientific community.
• Future research should focus on overcoming these hurdles to improve patient outcomes for neurological and psychiatric conditions.